Galecto Correlations
| GLTO Stock | USD 29.49 0.41 1.41% |
The current 90-days correlation between Galecto and Transcode Therapeutics is 0.26 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Galecto moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Galecto moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Galecto Correlation With Market
Significant diversification
The correlation between Galecto and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Galecto and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Galecto Stock
| 0.61 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.7 | DNLI | Denali Therapeutics | PairCorr |
| 0.7 | DNTH | Dianthus Therapeutics | PairCorr |
| 0.67 | VCYT | Veracyte | PairCorr |
| 0.78 | VERA | Vera Therapeutics | PairCorr |
| 0.78 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.8 | DSGN | Design Therapeutics | PairCorr |
| 0.79 | 0P6S | Bayer AG NA | PairCorr |
| 0.72 | DVAX | Dynavax Technologies Trending | PairCorr |
| 0.63 | VKTX | Viking Therapeutics | PairCorr |
| 0.86 | VRDN | Viridian Therapeutics | PairCorr |
| 0.84 | VRTX | Vertex Pharmaceuticals | PairCorr |
Moving against Galecto Stock
| 0.82 | PYC | Physiomics Plc | PairCorr |
| 0.79 | DRMA | Dermata Therapeutics Buyout Trend | PairCorr |
| 0.76 | DYAI | Dyadic International | PairCorr |
| 0.67 | VINC | Vincerx Pharma, Common | PairCorr |
| 0.66 | AVH | Avita Medical | PairCorr |
| 0.65 | VALN | Valneva SE ADR | PairCorr |
| 0.64 | VIVS | VivoSim Labs, Symbol Change | PairCorr |
| 0.63 | EQ | Equillium Buyout Trend | PairCorr |
| 0.63 | 688578 | Shanghai Allist Phar | PairCorr |
| 0.52 | RAC | Race Oncology | PairCorr |
| 0.52 | DTIL | Precision BioSciences | PairCorr |
| 0.43 | VANI | Vivani Medical | PairCorr |
| 0.31 | CMB | Cambium Bio | PairCorr |
| 0.83 | ELUT | Elutia Inc | PairCorr |
| 0.79 | MRVL | Marvel Biosciences Corp | PairCorr |
| 0.79 | ENSC | Ensysce Biosciences | PairCorr |
| 0.74 | ELDN | Eledon Pharmaceuticals | PairCorr |
| 0.74 | 300676 | BGI Genomics | PairCorr |
| 0.72 | ALA | Arovella Therapeutics | PairCorr |
| 0.69 | CDTTW | Conduit Pharmaceuticals | PairCorr |
| 0.69 | EDSA | Edesa Biotech | PairCorr |
Related Correlations Analysis
Risk-Adjusted Indicators
There is a big difference between Galecto Stock performing well and Galecto Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Galecto's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RNAZ | 4.03 | (0.54) | 0.00 | (1.31) | 0.00 | 9.74 | 30.84 | |||
| PHIO | 2.98 | (1.26) | 0.00 | (0.40) | 0.00 | 4.88 | 19.57 | |||
| APRE | 2.98 | (0.72) | 0.00 | (0.28) | 0.00 | 4.40 | 17.87 | |||
| KPRX | 2.72 | (0.34) | 0.00 | (0.16) | 0.00 | 5.70 | 21.80 | |||
| INAB | 4.03 | (0.27) | 0.00 | (0.05) | 0.00 | 10.97 | 27.61 | |||
| ACXP | 6.05 | 0.30 | 0.05 | 0.36 | 5.24 | 10.99 | 99.56 | |||
| APVO | 4.20 | (0.75) | 0.00 | (0.26) | 0.00 | 8.54 | 36.30 | |||
| LYRA | 3.98 | (0.85) | 0.00 | (0.47) | 0.00 | 7.51 | 30.53 | |||
| ADIL | 2.87 | (0.47) | 0.00 | (0.32) | 0.00 | 5.71 | 18.11 | |||
| BCDA | 3.49 | 0.22 | 0.07 | 0.18 | 3.79 | 7.58 | 37.37 |
Galecto Corporate Management
| Garrett Esq | General VP | Profile | |
| CPA CPA | Chief Officer | Profile | |
| Ulf Nilsson | CoFounder | Profile | |
| Hakon Leffler | CoFounder | Profile | |
| Lori Firmani | Interim Officer | Profile |